medical abortion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Female patients aged 18 to 45 years; 2: Confirmed intrauterine pregnancy by ultrasonography, with a gestational age of <= 63 days (calculated from the first day of the last menstrual period); 3: Decision to undergo medical abortion using the mifepristone and misoprostol regimen; 4: No contraindications to the use of mifepristone or misoprostol; 5: Ability and willingness to comply with the follow-up procedures outlined in the study protocol; 6: Understanding of the study purpose and voluntary provision of informed consent.
Exclusion criteria
Exclusion criteria: 1: Suspected or confirmed ectopic pregnancy or molar pregnancy; 2: Presence of any known contraindication to medical abortion (e.g., chronic adrenal failure, long-term corticosteroid therapy, glaucoma, severe asthma, bleeding disorders, or known allergy to the drugs used); 3: Coexisting severe systemic disease (e.g., cardiac, hepatic, or renal insufficiency); 4: Inability to adhere to the scheduled follow-up visits or lack of reliable contact information; 5: Concurrent participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete abortion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Imcomplete abortion;Persistent pregnancy; | — |
Countries
China
Contacts
The First Affiliated Hospital of Zhejiang Chinese Medical University